Grigeo (GRG1L) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
13 Jun, 2025Executive summary
Revenue rose by 1% to €104.3m over 6 months of 2024 compared to the same period last year, while EBITDA fell by 24% and profit before tax dropped by 31%.
Tissue paper segment revenue grew 6.1% year-over-year, but gross margin declined due to higher raw material costs.
Wood fibre boards segment maintained revenue but saw gross profit surge 77% and margin rise from 13.5% to 24.1%.
Raw materials for corrugated cardboard segment revenue fell 3.9% year-over-year, with gross margin down to 20.4%.
Financial highlights
Net profit for 6 months was €10.0m, down from €14.6m year-over-year.
Adjusted EBITDA was €16.7m, a 24% decrease from €22.0m in the prior year.
Gross margin declined to 23.4% from 26.0% year-over-year.
Basic EPS was €0.080, down from €0.111; diluted EPS was €0.079, down from €0.110.
Cash and cash equivalents at period end were €13.7m, down from €19.0m at year-end 2023.
Outlook and guidance
Management notes ongoing uncertainty due to the war in Ukraine, especially regarding the Ukrainian subsidiary Mena Pak AT.
No material events or changes in risk factors after the reporting period.
Latest events from Grigeo
- Revenue up 16% YoY, but profit and margins fell; expansion and legal risks remain.GRG1L
Q4 202525 Feb 2026 - Revenue up 9% but margins and net profit declined amid legal and geopolitical risks.GRG1L
Q3 202521 Nov 2025 - Revenue up 12% but profit and margins down; EUR 106m tissue investment planned.GRG1L
Q2 202522 Aug 2025 - Revenue up, but profit and margins down; legal and geopolitical risks remain elevated.GRG1L
Q3 202413 Jun 2025 - Revenue up 22% but margins and profit before tax declined amid ongoing legal risks.GRG1L
Q1 20256 Jun 2025 - Revenue up 9% but profit down 13% amid margin pressure and legal risks.GRG1L
Q4 20246 Jun 2025